Seroprotection ten years after fractional dose yellow fever vaccination

Follow-up study: Neutralizing antibody titers 10 years after intradermal fractional dose (0.1mL) yellow vaccination, compared to standard dose (0.5mL) yellow fever vaccine subcutaneously administered

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29660

Enrollment

155

Registered

2018-03-13

Start date

2017-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long term induced seroprotection after fractional dose yellow fever vaccine

Interventions

Blood sample (one)

Eligibility

Inclusion criteria

Inclusion criteria: Participants of a non-inferiority randomized controlled trial conducted in 2007-2008, investigating the immune response after yellow fever vaccine in fractional dose intradermally administered

Exclusion criteria

Exclusion criteria: immune disorder developed after the initial trial, booster yellow fever vaccination after the initial trial

Design outcomes

Primary

Measure	Time frame
Neutralizing antibody response ten years after yellow fever vaccination	—

Contacts

Public ContactA.H.E. Roukens

a.h.e.roukens@lumc.nl071-5262613 (secretariaat Infectieziekten)

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)